ErtemAGEfeTHYaylaC. Endocan: endothelial dysfunction, inflammation, or both?Angiology. 2017;68(1):79.
2.
QiuCRFuQSuiJ. Serum endothelial cell-specific molecule 1 (Endocan) level in patients with acute myocardial infarction and its clinical significance: a pilot study [published online May 25, 2016]. Angiology. 2016. doi:10.1177/0003319716651349.
3.
LassallePMoletSJaninA. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271(34):20458–20464.
4.
KundiHBalunACicekciogluH. Admission endocan level may be a useful predictor for in-hospital mortality and coronary severity index in patients with ST-segment elevation myocardial infarction. Angiology. 2017;68(1):46–51.
5.
BaltaSMikhailidisDPDemirkolS. Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014;65(9):773–777.
6.
ErtemAGEfeTHYaylaC. The association between serum procalcitonin levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute coronary syndrome. Angiology. 2017;68(1):40–45.
7.
GensiniGG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.
8.
NikiTSoekiTYamaguchiK. Elevated concentration of interferon-inducible protein of 10 kD (IP-10) is associated with coronary atherosclerosis. Int Heart J. 2015;56(3):269–272.
